Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumors × ulixertinib × Clear all

NCT01781429 2020-03-20

Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies

Phase 1/2 Completed

136 enrolled 25 charts

Other solid neoplasm

Advanced Solid Tumors